Association between triglyceride-glucose body mass index and future risk of arthritis in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3: A national prospective cohort study
- 1Department of Acupuncture and Moxibustion, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
- 2School of Acupuncture, Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, China.
Abstract
Cardiovascular-kidney-metabolic (CKM) syndrome encompasses interrelated cardiovascular, renal and metabolic disorders. Arthritis is linked to CKM multimorbidity, but the association between triglyceride-glucose body mass index (TyG-BMI), a surrogate marker of insulin resistance and incident arthritis across the CKM spectrum remains unclear. We analyzed data from the CHARLS cohort, including 5018 participants aged ≥45 years with CKM stages 0 to 3. Analytical approaches included multivariable logistic regression, restricted cubic splines, stratified and mediation analyses. Incident arthritis was defined by self-reported physician diagnosis, without confirmation via medical records. During follow-up, 2307 participants (45.97%) developed incident arthritis. Each one-standard-deviation increase in triglyceride-glucose body mass index (triglyceride-glucose body mass index) was associated with an 11% higher risk of arthritis (odds ratio [OR] = 1.11, 95% confidence interval [CI]: 1.04–1.19), with an approximately linear positive dose-response trend. The association appeared stronger in participants with sleep duration <7 hours (OR = 1.19, 95% CI: 1.08–1.31) and those at CKM stage 1 (OR = 1.57, 95% CI: 1.20–2.05). Exploratory mediation analyses suggested negative mediating roles of HDL-C and, marginally, BUN. Triglyceride-glucose body mass index exhibited an independent positive association with incident arthritis across CKM stages 0 to 3 and may serve as a practical indicator for early risk stratification.
Related
- Comparison analysis of the triglyceride-glucose index, triglyceride-glucose and frailty index in cardiovascular disease and mortality association among patients with rheumatoid arthritis: A population-based cohort study.
- Association of sleep time with all-cause and cardiovascular mortality among individuals with advanced cardiovascular-kidney-metabolic syndrome : A NHANES-based prospective cohort study
- Association of Homocysteine With All-Cause and Cardiovascular Mortality in Individuals With Advanced Cardiovascular-Kidney-Metabolic Syndrome: A Nationwide Prospective Cohort Study
- Triglyceride-glucose index combined with DAS28-ESR predicts cardiovascular disease risk in patients with rheumatoid arthritis: a national multicenter cohort study
- Association of the triglyceride-glucose index with dynamic bidirectional transitions of cardiovascular-kidney-metabolic syndrome: a multistate Markov model study based on CHARLS
BibTeX
@article{yan2026association,
title = {{Association between triglyceride-glucose body mass index and future risk of arthritis in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3: A national prospective cohort study}},
author = {Haokun Yan and Yaojia Yang and Baixiao Zhao},
journal = {Medicine},
year = {2026},
month = nov,
doi = {10.1097/md.0000000000051396},
url = {https://doi.org/10.1097/md.0000000000051396},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Association between triglyceride-glucose body mass index and future risk of arthritis in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3: A national prospective cohort study
AU - Haokun Yan
AU - Yaojia Yang
AU - Baixiao Zhao
PY - 2026
DA - 2026/11/06
JO - Medicine
DO - 10.1097/md.0000000000051396
UR - https://doi.org/10.1097/md.0000000000051396
AB - Cardiovascular-kidney-metabolic (CKM) syndrome encompasses interrelated cardiovascular, renal and metabolic disorders. Arthritis is linked to CKM multimorbidity, but the association between triglyceride-glucose body mass index (TyG-BMI), a surrogate marker of insulin resistance and incident arthritis across the CKM spectrum remains unclear. We analyzed data from the CHARLS cohort, including 5018 participants aged ≥45 years with CKM stages 0 to 3. Analytical approaches included multivariable logistic regression, restricted cubic splines, stratified and mediation analyses. Incident arthritis was defined by self-reported physician diagnosis, without confirmation via medical records. During follow-up, 2307 participants (45.97%) developed incident arthritis. Each one-standard-deviation increase in triglyceride-glucose body mass index (triglyceride-glucose body mass index) was associated with an 11% higher risk of arthritis (odds ratio [OR] = 1.11, 95% confidence interval [CI]: 1.04–1.19), with an approximately linear positive dose-response trend. The association appeared stronger in participants with sleep duration <7 hours (OR = 1.19, 95% CI: 1.08–1.31) and those at CKM stage 1 (OR = 1.57, 95% CI: 1.20–2.05). Exploratory mediation analyses suggested negative mediating roles of HDL-C and, marginally, BUN. Triglyceride-glucose body mass index exhibited an independent positive association with incident arthritis across CKM stages 0 to 3 and may serve as a practical indicator for early risk stratification.
SN - 0025-7974
SN - 1536-5964
ER -